Led by JY Bonnefoy, PhD, a serial entrepreneur experienced in oncology R&D from bench to patients, both with big pharmas and start-ups, Salto Therapeutics is focusing on new treatments for rare pediatric cancers. Our business model is to in-license early stage assets and to develop them in the clinic targeting approvals in the US & EU. We are currently operating in a stealth mode.
Company Details
- Employees
- 1
- Founded
- -
- Address
- Strasbourg, Fr
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- HQ
- Strasbourg
Salto Therapeutics Questions
Salto Therapeutics's LinkedIn profile is https://fr.linkedin.com/company/salto-therapeutics
Salto Therapeutics has
1 employees.
View email and phone details for 1
employees at Salto Therapeutics.
Salto Therapeutics's industry is
Biotechnology Research
Salto Therapeutics's top competitors are
Eligo Bioscience,
Recobia Therapeutics,
Celyad Oncology,
Syndivia,
Serendip Innovations,
Anagenesis Biotechnologies,
Bioaster,
Biosynex Pharma,
Lamina Therapeutics,
Domain Therapeutics.
Salto Therapeutics's categories are Biotechnology Research
Salto Therapeutics's founding year is 2022
